News List

Dr Reddy\'s exploits GE Healthcare\'s FlexFactory to power biologics production capacity expansion

GE Healthcare will help Dr Reddy\'s to install India\'s first-ever FlexFactory — a single-use manufacturing platform to expand biologics production capacity

By Team ABLE

GE Healthcare has won a deal from Dr Reddy\'s Laboratories Limited to install India\'s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India.

FlexFactory is expected to make Dr Reddy\'s biopharmaceutical manufacturing set-up more flexible and efficient, strengthening the company\'s position in the global biosimilars market and allowing Dr. Reddy\'s to continue increasing patient access across the world for biotech-based therapies.

The new FlexFactory will help Dr Reddy\'s increase its capacity to meet both the expected growth of its currently marketed biosimilars as well as support the launch of a significant portfolio of new biosimilar products in the years to come. With FlexFactory, Dr. Reddy\'s will be able to increase its manufacturing capacity swiftly as the overall project set-up timeline for FlexFactory is typically 9 to 12 months.

FlexFactory will enable Dr Reddy\'s transition from stainless steel to single-use technologies that bring enhanced flexibility and efficiency into their manufacturing set-up. Single-use technologies facilitate multi-product manufacturing and improve productivity by increasing the number of lots manufactured, as the change-over time between products can be reduced by 50% or more.